We are live on ! Find out more
ACA

Atlas Capital Advisors Portfolio holdings

AUM $875M
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$671M
AUM Growth
+$47.7M
Cap. Flow
+$22.7M
Cap. Flow %
3.38%
Top 10 Hldgs %
24.96%
Holding
980
New
34
Increased
174
Reduced
239
Closed
55

Sector Composition

Rank Sector Weight
1 Technology 12.63%
2 Financials 5.66%
3 Healthcare 4.82%
4 Consumer Staples 4.16%
5 Consumer Discretionary 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEP icon
501
Korea Electric Power
KEP
$16B
$52.3K 0.01%
5,719
-9,308
-62% -$88K
IAU icon
502
iShares Gold Trust
IAU
$64.4B
$52.2K 0.01%
1,500
-505
-25% -$17.3K
TUR icon
503
iShares MSCI Turkey ETF
TUR
$217M
$51.8K 0.01%
2,790
EA
504
DELISTED
Electronic Arts
EA
$51.8K 0.01%
393
-1,765
-82% -$237K
FISV
505
Fiserv Inc
FISV
$27.9B
$51.5K 0.01%
496
+31
+7% +$3.21K
XOM icon
506
ExxonMobil
XOM
$634B
$51.2K 0.01%
837
+120
+17% +$7.5K
JPM.PRM icon
507
JPMorgan Chase & Co 4.20% Series MM Preferred Stock
JPM.PRM
$1.34B
$51K 0.01%
+2,000
New +$50.1K
SNN icon
508
Smith & Nephew
SNN
$12.6B
$50.7K 0.01%
1,464
-5,828
-80% -$200K
TDY icon
509
Teledyne Technologies
TDY
$32B
$50.2K 0.01%
115
IR icon
510
Ingersoll Rand
IR
$33.7B
$49.9K 0.01%
807
FRC.PRM
511
DELISTED
First Republic Bank Depositary Shares, each representing a 1/40th interest in a share of 4.000% Noncumulative Perpetual Series M Preferred Stock
FRC.PRM
$49K 0.01%
+2,000
New +$47.8K
CSX icon
512
CSX Corp
CSX
$93.1B
$48.3K 0.01%
1,284
MSI icon
513
Motorola Solutions
MSI
$77.4B
$47.3K 0.01%
174
SNP
514
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$46.8K 0.01%
1,006
+129
+15% +$6.24K
RSP icon
515
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$46.7K 0.01%
286
DIA icon
516
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.5B
$45.4K 0.01%
125
-200
-62% -$71.1K
DFAU icon
517
Dimensional US Core Equity Market ETF
DFAU
$12.8B
$44.5K 0.01%
1,349
XBI icon
518
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$44.3K 0.01%
396
+63
+19% +$7.6K
XLNX
519
DELISTED
Xilinx Inc
XLNX
$44.3K 0.01%
209
TRMB icon
520
Trimble
TRMB
$13.9B
$44.2K 0.01%
507
HUM icon
521
Humana
HUM
$46.2B
$44.1K 0.01%
95
SCHG icon
522
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
$43.7K 0.01%
2,136
+840
+65% +$16.8K
UHS icon
523
Universal Health Services
UHS
$10.5B
$43.2K 0.01%
333
-370
-53% -$47.6K
CAG icon
524
Conagra Brands
CAG
$7.23B
$42.5K 0.01%
1,244
-510
-29% -$16.7K
LOGI icon
525
Logitech
LOGI
$15.2B
$41.2K 0.01%
500
-1,503
-75% -$125K

Similar funds

Atlas Capital Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Atlas Capital Advisors held 980 positions worth $671M, up 7.6% from $624M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Atlas Capital Advisors deployed $22.7M of net new capital in Q4 2021, opening 34 new positions and adding to 174 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 26,123 shares worth $1.32M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI USA Momentum Factor ETF, an estimated $5.9M trimmed.

  • Atlas Capital Advisors's largest Q4 2021 buy was JPMorgan Ultra-Short Income ETF: 26,123 shares worth $1.32M.
  • Atlas Capital Advisors added most to Vanguard Short-Term Bond ETF in Q4 2021, an estimated $25.9M increase.
  • Atlas Capital Advisors's biggest Q4 2021 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $5.9M.
  • Atlas Capital Advisors fully exited Vanguard Total Bond Market in Q4 2021, selling an estimated $501K.
  • Atlas Capital Advisors's ten largest holdings make up 25% of its $671M portfolio in Q4 2021.
  • Atlas Capital Advisors opened 34 new positions and closed 55 in Q4 2021.
  • Atlas Capital Advisors's portfolio value rose 7.6% quarter-over-quarter to $671M.

Based on Atlas Capital Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.